Astrocyte‐associated axonal damage in pre‐onset stages of experimental autoimmune encephalomyelitis

Recent studies of axon–glia and glia–glia communication have emphasized interactivity and interdependence between central nervous system (CNS) components. Concurrently, data from imaging, biochemical, and morphological studies have changed the view of multiple sclerosis (MS) from a neuroinflammatory condition with primary demyelination to one in which cumulative axonal damage drives progression. We therefore studied axonal damage in the context of inflammation and glial responses, from the pre‐clinical to onset stage of murine experimental autoimmune encephalomyelitis (EAE), an established MS model. We report three major findings: (1) the first evidence of axonal injury before significant T‐cell entry into the parenchyma, (3) coincidence of the earliest manifestation of axonal damage and astrocytic responses, and (3) an association between accumulation of axonal and astrocytic changes and specific forms of MS. These data demonstrate the relationship between the initiation of axonal injury and early inflammation. Significantly, we show that, in common with a growing number of neurodegenerative conditions, the pathology of murine EAE is characterized by early active contribution from astrocytes. This marks a change in the understanding of the role of astrocytes in MS pathogenesis and has important implications for the development of neuroprotective strategies. © 2005 Wiley‐Liss, Inc.

[1]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[2]  M. Levin,et al.  A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosis , 2003, Multiple sclerosis.

[3]  John Noseworthy,et al.  Multiple sclerosis: recent developments in neuropathology, pathogenesis, magnetic resonance imaging studies and treatment , 2001, Current opinion in neurology.

[4]  B. Trapp,et al.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease , 2003, Journal of the Neurological Sciences.

[5]  Sunhee C. Lee,et al.  Multiple Sclerosis: A Role for Astroglia in Active Demyelination Suggested by Class II MHC Expression and Ultrastructural Study , 1990, Journal of neuropathology and experimental neurology.

[6]  S. Yagishita,et al.  An Ultrastructural Study , 1979 .

[7]  R. Swanson,et al.  Astrocytes and Brain Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  James E Morgan,et al.  Optic nerve head structure in glaucoma: Astrocytes as mediators of axonal damage , 2000, Eye.

[9]  E. Frohman,et al.  Are astrocytes central players in the pathophysiology of multiple sclerosis? , 2003, Archives of neurology.

[10]  A. Unterberg,et al.  Mediators of Blood-Brain Barrier Dysfunction and Formation of Vasogenic Brain Edema , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  J. Kong,et al.  Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS) , 1999, Glia.

[12]  Manabu Onuki,et al.  Axonal degeneration is an early pathological feature in autoimmune‐mediated demyelination in mice , 2001, Microscopy research and technique.

[13]  L. Eng,et al.  Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): Immunohistochemical, light microscopic, and ultrastructural observations in the spinal cord , 1990, Glia.

[14]  H. Hartung,et al.  Animal models for autoimmune demyelinating disorders of the nervous system. , 2000, Molecular medicine today.

[15]  L. Eng,et al.  Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000) , 2000, Neurochemical Research.

[16]  O. Paulson,et al.  Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat , 1984, Brain Research.

[17]  B. Trapp,et al.  Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences , 2001, Current opinion in neurology.

[18]  Y. Itoyama,et al.  Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(−)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease , 2003, Journal of the Neurological Sciences.

[19]  Maiken Nedergaard,et al.  New roles for astrocytes (stars at last) , 2003, Trends in Neurosciences.

[20]  T. Johns,et al.  Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis , 1997, Journal of Molecular Medicine.

[21]  Helga E de Vries,et al.  The Blood‐Brain Barrier and Its Role in Immune Privilege in the Central Nervous System , 2003, Journal of neuropathology and experimental neurology.

[22]  R. Reynolds,et al.  Disturbed oligodendrocyte development and recovery from hypomyelination in a c‐myc transgenic mouse mutant , 2001, Journal of neuroscience research.

[23]  C M Jacque,et al.  Glial Fibrillary Acidic Protein , 2020, Definitions.

[24]  D. Catmull,et al.  Early glial responses in murine models of multiple sclerosis , 2004, Neurochemistry International.

[25]  C. Bernard,et al.  Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. , 1998, Autoimmunity.

[26]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.